Borwin Bandelow

Summary

Country: Germany

Publications

  1. ncbi What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    J Clin Psychiatry 67:1428-34. 2006
  2. ncbi Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention
    Borwin Bandelow
    University of Gottingen, Department of Psychiatry and Psychotherapy, Von Siebold Str 5, D 37075 Gottingen, Germany
    Expert Rev Neurother 7:769-81. 2007
  3. ncbi Escitalopram in the treatment of anxiety symptoms associated with depression
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    Depress Anxiety 24:53-61. 2007
  4. doi A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder
    Dirk Wedekind
    Department of Psychiatry and Psychotherapy, University of Goettingen, Goettingen, Germany
    World J Biol Psychiatry 11:904-13. 2010
  5. doi Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    Int J Psychiatry Clin Pract 16:77-84. 2012
  6. ncbi The quantification inventory for somatoform syndromes (QUISS): a novel instrument for the assessment of severity
    Dirk Wedekind
    Department of Psychiatry, University of Gottingen, Gottingen, Germany
    Eur Arch Psychiatry Clin Neurosci 257:153-63. 2007
  7. ncbi Panic disorder during pregnancy and postpartum period
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
    Eur Psychiatry 21:495-500. 2006
  8. ncbi Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, The University of Göttingen, Gottingen, Germany
    World J Biol Psychiatry 8:175-87. 2007
  9. doi Borderline personality disorder: a dysregulation of the endogenous opioid system?
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    Psychol Rev 117:623-36. 2010
  10. doi Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Goettingen, Germany
    Int J Neuropsychopharmacol 13:305-20. 2010

Detail Information

Publications34

  1. ncbi What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    J Clin Psychiatry 67:1428-34. 2006
    ..We also sought to compare the standardized effect sizes of escitalopram for these 4 psychiatric disorders...
  2. ncbi Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention
    Borwin Bandelow
    University of Gottingen, Department of Psychiatry and Psychotherapy, Von Siebold Str 5, D 37075 Gottingen, Germany
    Expert Rev Neurother 7:769-81. 2007
    ..Clinicians may consider the use of pregabalin in lieu of benzodiazepines as an alternative therapy for their patients with GAD...
  3. ncbi Escitalopram in the treatment of anxiety symptoms associated with depression
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    Depress Anxiety 24:53-61. 2007
    ..Escitalopram was significantly more effective compared to placebo in treating both anxiety symptoms and the entire depression in the total depressive population, as well as in depressive patients with a high degree of anxiety...
  4. doi A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder
    Dirk Wedekind
    Department of Psychiatry and Psychotherapy, University of Goettingen, Goettingen, Germany
    World J Biol Psychiatry 11:904-13. 2010
    ..Regular aerobic exercise (running) has been shown to be superior to a pill placebo in the treatment of panic disorder. Combined drug and exercise treatment has not been investigated in randomized controlled studies to date...
  5. doi Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    Int J Psychiatry Clin Pract 16:77-84. 2012
    ..Anxiety disorders are frequently under-diagnosed conditions in primary care, although they can be managed effectively by general practitioners...
  6. ncbi The quantification inventory for somatoform syndromes (QUISS): a novel instrument for the assessment of severity
    Dirk Wedekind
    Department of Psychiatry, University of Gottingen, Gottingen, Germany
    Eur Arch Psychiatry Clin Neurosci 257:153-63. 2007
    ..Characteristic cognitive and behavioural domains, representing severity are not incorporated in the existing scales. Results with the novel quantification inventory for somatoform syndromes (QUISS) are presented in this paper...
  7. ncbi Panic disorder during pregnancy and postpartum period
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
    Eur Psychiatry 21:495-500. 2006
    ..Earlier studies on the influence of pregnancy and postpartum period on the course of panic disorder have been inconsistent. The present study aims to quantify panic manifestations in these periods in large sample of women...
  8. ncbi Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, The University of Göttingen, Gottingen, Germany
    World J Biol Psychiatry 8:175-87. 2007
    ..We performed a meta-analysis, which only included studies using a direct comparison of pharmacological, psychological, or combined treatments...
  9. doi Borderline personality disorder: a dysregulation of the endogenous opioid system?
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    Psychol Rev 117:623-36. 2010
    ..An understanding of the neurobiology of BPD may help in developing new treatments for patients with this severe disorder...
  10. doi Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Goettingen, Germany
    Int J Neuropsychopharmacol 13:305-20. 2010
    ..8%, 150 mg, 5.0%; placebo, 1.8%; and paroxetine, 8.4%. Once-daily quetiapine XR is an effective and generally well-tolerated treatment for patients with GAD, with symptom improvement seen as early as day 4...
  11. doi Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with depressive disorder and healthy controls
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    Int J Psychiatry Clin Pract 17:56-63. 2013
    ..Only few studies have compared the frequency of traumatic life events during childhood in inpatients with depression with a healthy control group...
  12. pmc Posttraumatic stress disorder (PTSD) in the German Armed Forces: a retrospective study in inpatients of a German army hospital
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Str 5, 37075, Gottingen, Germany
    Eur Arch Psychiatry Clin Neurosci 262:459-67. 2012
    ..8% vs. 5.17%). A careful psychiatric screening before recruitment might help to identify persons at risk of PTSD...
  13. ncbi Defining response and remission in anxiety disorders: toward an integrated approach
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    CNS Spectr 11:21-8. 2006
    ....
  14. doi World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    World J Biol Psychiatry 9:248-312. 2008
    ....
  15. pmc The diagnosis and treatment of generalized anxiety disorder
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University Medical Center Gottingen, Germany
    Dtsch Arztebl Int 110:300-9; quiz 310. 2013
    ..Generalized anxiety disorder (GAD) is a common and serious disease with a lifetime prevalence of 4.3% to 5.9%. It is underdiagnosed in primary care...
  16. doi Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect?
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Gottingen, Germany
    World J Biol Psychiatry 11:66-70. 2010
    ..0195), respectively, was observed. The present results provide further support for a potentially male-specific role of the less active ACE I allele in the pathogenesis of panic disorder, possibly by altering substance P levels...
  17. ncbi Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Str 5, D 37075, Gottingen, Germany
    Psychiatry Res 134:169-79. 2005
    ..The present data support the hypothesis that the etiology of BPD is multifactorial and that familial psychiatric disorders and sexual abuse are contributing factors...
  18. pmc Neuroimaging in anxiety disorders
    Kirsten Engel
    Department of Psychiatry and Psychotherapy, Anxiety Research Unit, University of Goettingen, Von Siebold Strasse 5, 37075 Goettingen, Germany
    J Neural Transm 116:703-16. 2009
    ..An overview of neuroimaging investigations in anxiety disorders is given after a brief summary of results from healthy volunteers. Concluding implications for future research are made by the authors...
  19. ncbi Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Strasse 5, D 37505 Göttingen, Germany
    J Clin Psychiatry 65:405-13. 2004
    ..The purpose of this study was to compare sertraline and paroxetine in the acute treatment of panic disorder...
  20. ncbi Treatment-resistant panic disorder
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
    CNS Spectr 9:725-39. 2004
    ..According to existing studies, a combination of pharmacologic treatment with cognitive-behavioral therapy can be recommended...
  21. pmc Attachment style, anxiety coping, and personality-styles in withdrawn alcohol addicted inpatients
    Dirk Wedekind
    Department of Psychiatry and Psychotherapy, University of Gottingen, Von Siebold Strasse 5, 37075 Goettingen, Germany
    Subst Abuse Treat Prev Policy 8:1. 2013
    ....
  22. ncbi Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, The University of Göttingen, Gottingen, Germany
    Compr Psychiatry 43:269-78. 2002
    ..Owing to the retrospective nature of the data, the results have to be interpreted with caution...
  23. ncbi World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders
    Borwin Bandelow
    Department of Psychiatry and Psychotherapy, University of Gottingen, Germany
    World J Biol Psychiatry 3:171-99. 2002
    ..For social phobia, SSRIs are recommended for the first line, and MAOIs, moclobemide and benzodiazepines as second line. Obsessive-compulsive disorder is best treated with SSRIs or clomipramine...
  24. ncbi Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram
    Dan J Stein
    Department of Psychiatry, University of Cape Town, South Africa
    J Clin Psychiatry 67:1741-6. 2006
    ....
  25. ncbi Assessing the severity of panic disorder and agoraphobia: validity, reliability and objectivity of the Turkish translation of the Panic and Agoraphobia Scale (P&A)
    Umit Tural
    School of Medicine, Dokuz Eylul University, Izmir, Turkey
    J Anxiety Disord 16:331-40. 2002
    ..88 and .86, respectively. The Turkish version of the P&A has yielded good psychometric properties and was found to be a reliable instrument for assessing severity in panic disorder...
  26. ncbi WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults
    John H Greist
    Healthcare Technology Systems, Inc, Madison, Wisconsin 53717, USA
    CNS Spectr 8:7-16. 2003
    ..Further, pharmacotherapy for a minimum of 1-2 years is recommended before very gradual withdrawal may be considered...
  27. ncbi WCA recommendations for the long-term treatment of panic disorder
    Mark H Pollack
    Division of Psychiatry, Huddinge University Hospital, Stockholm, Sweden
    CNS Spectr 8:17-30. 2003
    ..Long-term efficacy and ease of use are important considerations in treatment selection, as maintenance treatment is recommended for at least 12-24 months, and in some cases, indefinitely...
  28. ncbi WCA Recommendations for the long-term treatment of posttraumatic stress disorder
    Dan J Stein
    Medical Research Council Research Unit on Anxiety Disorder, University of Stellenbosch, Cape Town, Tygerberg, South Africa
    CNS Spectr 8:31-9. 2003
    ..Only SSRIs have been proven effective and safe in long-term randomized controlled trials. Current guidelines from the Expert Consensus Panel for PTSD recommend treatment of chronic PTSD for a minimum of 12-24 months...
  29. ncbi WCA recommendations for the long-term treatment of social phobia
    Michael Van Ameringen
    Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada
    CNS Spectr 8:40-52. 2003
    ..In light of the chronicity and disability associated with social phobia, as well as the high relapse rate after short-term therapy, it is recommended that effective treatment be continued for at least 12 months...
  30. ncbi WCA recommendations for the long-term treatment of generalized anxiety disorder
    Christer Allgulander
    Department of Psychiatry, Harvard University School of Medicine, Boston, Massachusetts, USA
    CNS Spectr 8:53-61. 2003
    ..Treatment gains after a 12-week course of CBT may be maintained for up to 1 year. Currently, no guidelines exist for the long-term treatment of GAD...
  31. ncbi Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder
    Borwin Bandelow
    Dept of Psychiatry and Psychotherapy, The University of Göttingen, Von Siebold Str 5, 37075 Gottingen, Germany
    Eur Arch Psychiatry Clin Neurosci 254:397-405. 2004
    ..Childhood traumatic experiences, rearing styles, familial mental disorders and birth risk factors have been associated with the development of social anxiety disorder...
  32. ncbi Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
    David S Baldwin
    Division of Clinical Neurosciences, University of Southampton, Southampton, UK
    J Psychopharmacol 19:567-96. 2005
    ..The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments...
  33. doi Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder
    Martin E Keck
    Max Planck Institute of Psychiatry, Munich, Germany
    Am J Med Genet B Neuropsychiatr Genet 147:1196-204. 2008
    ..These data suggest that polymorphisms in the AVPR1B and the CRHR1 genes alter the susceptibility to panic disorder...
  34. ncbi Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants
    Katharina Domschke
    Department of Psychiatry, University of Muenster, Muenster, Germany
    Am J Med Genet B Neuropsychiatr Genet 147:510-6. 2008
    ..However, in order to allow for conclusive evaluation of the present finding and to exclude a false positive result, further studies in larger, independent, preferably family based samples are warranted...